SMA
GILD icon

Sage Mountain Advisors’s Gilead Sciences GILD Stock Holding History

Sage Mountain Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,797
Closed -$1.08M – 406
2025
Q4 		$1.08M Buy
8,797
+193
+2% +$23.5K 0.06% 152
2025
Q3 		$955K Buy
8,604
+847
+11% +$96.3K 0.05% 166
2025
Q2 		$860K Buy
7,757
+1,022
+15% +$109K 0.06% 165
2025
Q1 		$755K Buy
6,735
+623
+10% +$64.3K 0.06% 157
2024
Q4 		$565K Buy
6,112
+1,023
+20% +$92.1K 0.04% 189
2024
Q3 		$427K Buy
5,089
+1,195
+31% +$91.2K 0.04% 228
2024
Q2 		$267K Buy
3,894
+520
+15% +$34.7K 0.02% 280
2024
Q1 		$247K Sell
3,374
-343
-9% -$26.4K 0.03% 283
2023
Q4 		$301K Buy
3,717
+345
+10% +$26.8K 0.03% 201
2023
Q3 		$253K Buy
3,372
+47
+1% +$3.62K 0.03% 208
2023
Q2 		$256K Buy
3,325
+80
+2% +$6.38K 0.04% 204
2023
Q1 		$269K Buy
+3,245
New +$269K 0.04% 182
2022
Q1 		– Sell
-5,062
Closed -$368K – 652
2021
Q4 		$368K Buy
5,062
+363
+8% +$25K 0.04% 390
2021
Q3 		$328K Sell
4,699
-31
-0.7% -$2.18K 0.05% 339
2021
Q2 		$326K Buy
+4,730
New +$316K 0.05% 303

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sage Mountain Advisors's GILD Position: Q1 2026 in Review

Sage Mountain Advisors sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 8,797 shares — an estimated $1.08M sold.

Sage Mountain Advisors first reported a position in GILD in Q2 2021 and held it in 15 quarters. The position peaked at $1.08M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Sage Mountain Advisors reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Sage Mountain Advisors sold 8,797 Gilead Sciences shares in Q1 2026, an estimated $1.08M.
  • Sage Mountain Advisors first reported a position in Gilead Sciences in Q2 2021 and held it in 15 quarters.
  • Sage Mountain Advisors's Gilead Sciences position peaked at $1.08M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sage Mountain Advisors's 13F filing for Q1 2026, filed 11 May 2026.